|1.||Bifulco, Maurizio: 5 articles (04/2010 - 09/2003)|
|2.||Laezza, Chiara: 4 articles (12/2008 - 09/2003)|
|3.||Pisanti, Simona: 3 articles (12/2008 - 02/2006)|
|4.||Laccetti, Paolo: 2 articles (04/2010 - 09/2003)|
|5.||Malfitano, Anna Maria: 2 articles (12/2008 - 02/2006)|
|6.||Portella, Giuseppe: 2 articles (02/2006 - 09/2003)|
|7.||Di Marzo, Vincenzo: 2 articles (02/2006 - 09/2003)|
|8.||Bujalska-Zadrożny, Magdalena: 1 article (04/2015)|
|9.||de Cordé, Anna: 1 article (04/2015)|
|10.||Pawlik, Karolina: 1 article (04/2015)|
05/01/2007 - "Therefore, the aim of this study was to assess the anti-angiogenic activity of Met-F-AEA, to investigate the molecular mechanisms underlying this effect and whether Met-F-AEA could antagonize tumor-induced endothelial cell sprouting. "
12/01/2008 - "We suggest that the inhibitory effect of Met-F-AEA on tumor cell migration could be related to RHOA-ROCK-dependent signaling pathway."
09/01/2003 - "Here we report that Met-F-AEA also blocks the growth of tumors previously induced in nude mice by the s.c. "
12/01/2001 - "Met-F-AEA (0.5 mg/kg/dose) induced a drastic reduction in tumor volume. "
05/15/2014 - "Tumors derived from Met-F-AEA and URB597 combination treated mice showed reduced EGFR, AKT and ERK activation and MMP2/MMP9 expressions when compared to Met-F-AEA or URB597 alone. "
|2.||Thyroid Neoplasms (Thyroid Cancer)
04/01/2010 - "This study provides new insights into the mechanism of Met-F-AEA action, and could have significance in providing a basis for the management of thyroid carcinoma."
04/01/2010 - "A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis."
09/01/2003 - "Met-F-AEA inhibited in vitro the growth of a metastasis-derived thyroid cancer cell line more potently than a primary cancer cell line. "
05/01/2007 - "We have previously observed that the metabolically stable anandamide analog, 2-methyl-2'-F-anandamide (Met-F-AEA) can inhibit the growth of thyroid cancer in vivo. "
09/01/2003 - "Stimulation of cannabinoid CB1 receptors by 2-methyl-arachidonyl-2'-fluoro-ethylamide (Met-F-AEA) inhibits the growth of a rat thyroid cancer cell-derived tumor in athymic mice by inhibiting the activity of the oncogene product p21ras. "
|3.||Breast Neoplasms (Breast Cancer)
12/01/2008 - "The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway."
02/15/2006 - "In MDA-MB-231 cells, a highly invasive human breast cancer cell line, and in TSA-E1 cells, a murine breast cancer cell line, Met-F-AEA inhibited adhesion and migration on type IV collagen in vitro without modifying integrin expression: both these effects were antagonized by SR141716A. "
|4.||Neuralgia (Stump Neuralgia)
|5.||Neoplasm Metastasis (Metastasis)
|3.||Cannabinoid Receptors (Cannabinoid Receptor)
|7.||Cyclin-Dependent Kinase Inhibitor p27
|9.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|10.||Collagen Type IV (Type IV Collagen)